Exponent (EXPO) Cash & Equivalents (2010 - 2026)

Exponent has disclosed Cash & Equivalents across 17 years of filings, most recently posting $118.6 million for Q2 2026.

• Quarterly Cash & Equivalents fell 51.63% year-over-year to $118.6 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $118.6 million (down 51.63% YoY) and the FY2026 annual result came in at $221.9 million, down 14.28% from the prior year.
• Cash & Equivalents fell to $118.6 million in Q2 2026, from $221.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $258.9 million in Q1 2025 and troughed at $118.6 million in Q2 2026.
• A 5-year average of $186.1 million and a median of $187.2 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 60.25% — and 2026, when it plunged 51.63%.
• Tracing EXPO's Cash & Equivalents over 5 years: stood at $161.5 million in 2022, then climbed by 15.91% to $187.2 million in 2023, then increased by 17.4% to $219.7 million in 2024, then dropped by 5.61% to $207.4 million in 2025, then plunged by 42.83% to $118.6 million in 2026.
• Business Quant data shows EXPO's Cash & Equivalents at $118.6 million in Q2 2026, $221.9 million in Q1 2026, and $207.4 million in Q4 2025.